drugset / Trial / NCT00641953

IMX-150 Cream for Diabetic Neuropathy

NCT00641953

Phase 2 Completed 155 enrolled Procris Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the effectiveness of two different dose of IMX-150 to that of placebo (non-active) in the treatment of diabetic peripheral neuropathy pain of the feet.

Timeline

Start
2007-08
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitroglycerin Unknown 0.3 % Topical
Subject Nitroglycerin Unknown 0.6 % Topical

Indications